Treatment of tobacco dependence in cancer patients - Recommendations of the Section of Supportive Treatment and Care and the Section of Preventive Oncology of the Czech Cancer Society of the Czech Medical Association of J. E. Purkyně, Working Group for the Prevention and Treatment of Tobacco Dependence of the Czech Medical Association of J. E. Purkyně, and the Society for Treatment of Tobacco Dependence

Czech version

Authors: K. Zvolská ¹; E. Králíková ^1,2; S. Vokurka ³; J. Halámková ⁴; A. Strnadová ⁵
Authors‘ workplace: Centrum pro závislé na tabáku III. interní kliniky – kliniky endokrinologie a metabolizmu 1. LF UK a VFN v Praze ¹; Ústav hygieny a epidemiologie, 1. LF UK a VFN v Praze ²; Onkologická a radioterapeutická klinika LF v Plzni UK a FN Plzeň ³; Klinika komplexní onkologické péče LF MU a MOÚ Brno ⁴; Odbor ošetřovatelství a nelékařských povolání, MZ ČR, Praha ⁵
Published in: Klin Onkol 2024; 38(1): 63-67
Category: Short Communication
doi: https://doi.org/10.48095/ccko202463

Overview

Smoking is a significant risk factor for the development of many cancers. In addition, after a cancer diagnosis, it also has an adverse effect on survival, the course and effectiveness of cancer treatment and quality of life, and increases the likelihood of a number of other complications. Treating tobacco dependence reduces the risk of their occurrence or the extent of their consequences. A working group of authors from professional groups (the Section of Supportive Treatment and Care and the Section of Preventive Oncology of the Czech Society of Oncology of the Czech Medical Association of J. E. Purkyně, the Society for the Treatment of Tobacco Dependence, Czech Nurses Association, Working Group for the Prevention and Treatment of Tobacco Dependence of the Czech Medical Association J. E. P. and the Society for Treatment of Tobacco Dependence) prepared a simple basic scheme of intervention in contact with smokers in routine practice based on recommendations of professional societies, outcomes of studies, scientific literature and proven practice. A smoke-free environment, the importance of zero exposure to tobacco smoke, smoking cessation recommendations for smokers, relapse prevention for ex-smokers and the offer of tobacco dependence treatment should be a natural part of cancer care at least in the form of a brief DIK (abbreviation for “question – intervention – contact” in the Czech language) intervention. It is important to record smoking status, including exposure to second-hand smoke, in all patients, and to empathically repeat interventions in smokers (active and passive), including relapse prevention. This approach contributes to abstinence in cancer patients and thus to higher efficacy of cancer treatment, longer survival and reduction of other risks.

Keywords:

smoking – Clinical oncology – pharmacotherapy – tobacco use disorder – psychosocial intervention

Sources

1. Heiden B, Eaton D, Chang S et al. Association between persistent cigarette smoking and oncologic outcomes in stage I non-small cell lung cancer following surgery. Chest J 2021; 160(4): A1610. doi: 10.1016/ j.chest.2021.07.1469.

2. Jassem J. Declaration from IASLC: tobacco cessation after cancer diagnosis. [online]. Available from: https:/ / www.iaslc.org/ About-IASLC/ News-Detail/ declaration-from-iaslc-tobacco-cessation-after-cancer-diagnosis.

3. Kaiser EG, Prochaska JJ, Kendra MS. Tobacco cessation in oncology care. Oncology 2018; 95(3): 129–137. doi: 10.1159/ 000489266.

4. NCCN Clinical Practice Guidelines in Oncology. Smoking cessation – version 2.2019. [online]. Available from: https:/ / www2.trikobe.org/ nccn/ guideline/ lung/ english/ smoking.pdf.

5. ASCO. Tobacco cessation guide for oncology providers. [online]. Available from: https:/ / www.asco.org/ sites/ new-www.asco.org/ files/ tobacco-cessation-guide.pdf.

6. Cataldo JK, Dubey S, Prochaska JJ. Smoking cessation: an integral part of lung cancer treatment. Oncology 2010; 78(5–6): 289–301. doi: 10.1159/ 000319937.

7. Fucito LM, Czabafy S, Hendricks PS et al. Pairing smoking-cessation services with lung cancer screening: a clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco. Cancer 2016; 122(8):
1150–1159. doi: 10.1002/ cncr.29926.

8. Wender R, Fontham ET, Barrera E Jr et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013; 63(2): 107–117. doi: 10.3322/ caac.21
172.

9. Kazemzadeh Z, Manzari ZS, Pouresmail Z. Nursing interventions for smoking cessation in hospitalized patients: a systematic review. Int Nurs Rev 2017; 64(2): 263–275. doi: 10.1111/ inr.12320.

10. Parsons A, Daley A, Begh R et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta--analysis. BMJ 2010; 340: b5569. doi: 10.1136/ bmj.b5569.

11. Zhou W, Heist RS, Liu G et al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer 2006; 53(3): 375–380. doi: 10.1016/ j.lungcan.2006.05.017.

12. Gemine RE, Ghosal R, Collier G et al. Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small cell lung cancer. Lung Cancer 2019; 129: 1–7. doi: 10.1016/ j.lungcan.2018.12.028.

13. Roach MC, Rehman S, DeWees TA et al. It‘s never too late: smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival. Pract Radiat Oncol 2016; 6(1): 12–18. doi: 10.1016/ j.prro.2015.09.005.

14. Kassim R, Osei E, Cronin K. A review of the effects of tobacco smoking on cancer treatment: smoking cessation intervention should be integrated into the cancer care continuum. J Radiother Pract 2020; 19(1): 84–92. doi: 10.1017/ S1460396919000360.

15. Myers K, Hajek P, Hinds C et al. Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med 2011; 171(11): 983–989. doi: 10.1001/ archinternmed.2011.97.

16. Králíková E, Zvolská K, Štěpánková L et al. Tobacco dependence treatment guidelines. Cas Lek Cesk 2022; 161(1): 33–43.

17. Králíková E. Onkologický pacient a kouření: jak se ptát, motivovat a pomoci přestat. Podpůrná léčba 2022; 4(1): 28–31.

18. Králíková E, Aschermann M, Dvořák V et al. Léčba závislosti na tabáku – klinický souhrn. [online]. Dostupné z: https:/ / kdp.uzis.cz/ index.php?pg=kdp&id=56.

19. National Cancer Institute. Treating smoking in cancer patients: an essential component of cancer care. [online]. Available from: www.cancercontrol.cancer.gov/ monograph23.

20. Clinical Oncology Society of Australia. Smoking cessation in cancer patients: embedding smoking cessation care in Australian oncology health services. [online]. Available from: https:/ / cosa.org.au/ media/ 332692/ cosa-smoking-cessation-in-cancer-patients-140820-final.pdf.

21. Shields PG, Herbst RS, Arenberg D et al. Smoking cessation, version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016; 14(11):
1430–1468. doi: 10.6004/ jnccn.2016.0152.

22. Ahuja R, Weibel SB, Leone FT. Lung cancer: the oncologist‘s role in smoking cessation. Semin Oncol 2003; 30(1): 94–103. doi: 10.1053/ sonc.2003.50000.

23. SLZT. Odborná společnost lékařů a dalších zdravotníků, kteří se zabývají léčbou závislosti na tabáku. [online]. Dostupné z: www.slzt.cz.